D42H (p.Asp42His) variant of HTR2C (5-hydroxytryptamine receptor 2C)

D42H (p.Asp42His) in HTR2C (5-hydroxytryptamine receptor 2C) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.21 / 1. The record also includes population frequency data and structural context.

D42H (p.Asp42His) variant details